166 related articles for article (PubMed ID: 310549)
21. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
[TBL] [Abstract][Full Text] [Related]
22. Clinical observations and their relationship to laboratory findings in the haemophilias.
Rainsford SG; Hall A
Thromb Diath Haemorrh; 1975 Dec; 34(3):734-9. PubMed ID: 1082180
[TBL] [Abstract][Full Text] [Related]
23. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
Mahasandana C; Patharathienskul D; Suvatte V
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
[TBL] [Abstract][Full Text] [Related]
24. [Tooth extraction in hemophilia].
van Creveld S; Buchner R; de Vos-Bongaardt CM
Ned Tijdschr Tandheelkd; 1969 Oct; 76(10):711-32. PubMed ID: 5307345
[No Abstract] [Full Text] [Related]
25. [Hemorrhage problems in the ear, nose and throat].
Lakartidningen; 1974 Dec; 71(52):5377-89. PubMed ID: 4548728
[No Abstract] [Full Text] [Related]
26. [Factor VIII-like antigen in haemophilia A and in Willebrand's disease (author's transl)].
Blatný J; Procházka J; Bártová A; Fischerová E; Slepicka L; Skodová M
Cas Lek Cesk; 1975 Sep; 114(38):1174-6. PubMed ID: 1081010
[No Abstract] [Full Text] [Related]
27. [The management of the intracranial hemorrhage in hemophilia and the related diseases (author's transl)].
Ichinose A; Maruyama I; Igata A; Asakura T; Tokito S
Rinsho Shinkeigaku; 1981 Jun; 21(6):471-9. PubMed ID: 6794967
[No Abstract] [Full Text] [Related]
28. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
Orsini F; Rotschild C; Beurrier P; Faradji A; Goudemand J; Polack B
Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
[TBL] [Abstract][Full Text] [Related]
29. The management of patients with bleeding disorders.
Wyld PJ; Dawson KP
N Z Med J; 1984 Feb; 97(750):118-9. PubMed ID: 6424072
[No Abstract] [Full Text] [Related]
30. Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. A study of the cooperative group of hemophilia.
Ambriz-Fernández R; Reyna-Fregoso MP; Pizzuto-Chávez J; Rodríguez-Moyado H; Farfán-Canto JM; Trueba-Christy E; Collazo-Jaloma J
Arch Invest Med (Mex); 1985; 16(3):225-35. PubMed ID: 3938639
[No Abstract] [Full Text] [Related]
31. [Characteristics of the diagnosis, clinical aspects and treatment of hemophilias with specific, circulating anticoagulants].
Barkagan ZS; Sukhoveeva EIa; Eremin GF; Tolochko OI; Shevchenko VI
Probl Gematol Pereliv Krovi; 1972 Apr; 17(4):35-41. PubMed ID: 4680852
[No Abstract] [Full Text] [Related]
32. Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1.
Girolami A; Dal Bo Zanon R; Procidano M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):863-71. PubMed ID: 6176512
[TBL] [Abstract][Full Text] [Related]
33. Tooth extractions in hemophiliacs.
Ramström G; Blombäck M
Int J Oral Surg; 1975 Jan; 4(1):1-17. PubMed ID: 804454
[No Abstract] [Full Text] [Related]
34. [Determination of the deficient factor in hemophilic patients].
Peñaloza-Santillán JA; Arias y Arias J; Resano-Pérez F
Bol Med Hosp Infant Mex; 1975; 32(1):51-9. PubMed ID: 1109289
[No Abstract] [Full Text] [Related]
35. [Prevalence of inhibitors in hemophiliacs with reference to the transfusion of blood products (author's transl)].
Kamiya T
Rinsho Byori; 1978; 26(4):291-7. PubMed ID: 671775
[No Abstract] [Full Text] [Related]
36. [Treatment of hemophilias].
Fischer M; Deutsch E
Dtsch Med J; 1968 Jul; 19(14):499-505. PubMed ID: 5305713
[No Abstract] [Full Text] [Related]
37. [Molecular defect in hemophilia and von Willebrand's disease (author's transl)].
Fukui H
Rinsho Byori; 1976 Apr; 24(4):274-8. PubMed ID: 1084430
[No Abstract] [Full Text] [Related]
38. [Ristocetin-induced platelet aggregation in von Willebrand's disease, thrombasthenia and essential athrombia with special reference to AHF-like antigen (author's transl)].
Ishiguro J; Kondo M; Ogata K; Takahashi T; Kamiya T
Rinsho Ketsueki; 1975 Jul; 16(7):716-24. PubMed ID: 1080812
[No Abstract] [Full Text] [Related]
39. [Clinical features of our patients with von Willebrand's disease (author's transl)].
Takahashi H; Koike K; Itoh M; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A; Matsuoka M; Tsukada T
Rinsho Ketsueki; 1980 Feb; 21(2):179-88. PubMed ID: 6774127
[No Abstract] [Full Text] [Related]
40. [A clinical study of congenital factor XIII deficiency (author's transl)].
Nakamura K; Itakura T; Yoshioka T; Suou T; Imai A
Rinsho Ketsueki; 1977 May; 18(5):636-47. PubMed ID: 904084
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
